ProShare Advisors
CABA icon

ProShare Advisors’s Cabaletta Bio CABA Stock Holding History

ProShare Advisors’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.5K Buy
+20,086
New +$66.1K ﹤0.01% 1829
2025
Q1 		– Sell
-12,637
Closed -$28.7K – 2115
2024
Q4 		$28.7K Buy
12,637
+1,372
+12% +$4.82K ﹤0.01% 2237
2024
Q3 		$53.2K Buy
+11,265
New +$65.2K ﹤0.01% 1973

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

ProShare Advisors's CABA Position: Q2 2026 in Review

ProShare Advisors opened a new position in Cabaletta Bio (CABA) in Q2 2026: 20,086 shares worth $62.5K. The stake represents ﹤0.01% of the portfolio and ranks #1829 among its holdings. This is a return to the name: ProShare Advisors previously reported a position in CABA as recently as Q4 2024.

ProShare Advisors first reported a position in CABA in Q3 2024 and has held it in 3 quarters since. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • ProShare Advisors held 20,086 shares of Cabaletta Bio worth $62.5K as of Q2 2026.
  • Cabaletta Bio was a new ProShare Advisors position in Q2 2026.
  • Cabaletta Bio made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #1829 holding.
  • ProShare Advisors first reported a position in Cabaletta Bio in Q3 2024 and has held it in 3 quarters since.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.